{"id":"tiotropium-2-5-g-b-i-d","_chembl":null,"allNames":"tiotropium 2.5 µg b.i.d","_dailymed":null,"mechanism":{"target":"M3","drugClass":"Muscarinic antagonist","explanation":"Tiotropium 2.5 µg b.i.d works by blocking muscarinic receptors in the lungs, which helps relax the muscles around the airways and makes breathing easier. This effect is achieved through its action on the M3 receptor, a key player in airway smooth muscle contraction.","oneSentence":"Tiotropium 2.5 µg b.i.d acts as an anticholinergic by blocking muscarinic receptors, leading to bronchodilation in the airways."},"_scrapedAt":"2026-03-28T01:48:03.409Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:48:45.008319+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Tiotropium 2.5 µg b.i.d","genericName":"tiotropium-2-5-g-b-i-d","companyName":"Pfizer Inc.","companyId":"pfizer","modality":"","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":4,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:48:45.008319+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}